InVivoPath
Guiding Your Path — From Study Design to Data-Driven Decisions.
Expert Fractional Preclinical Strategy for Metabolic, Fibrotic, and Neurodegenerative Drug Development for Lean Biotechs
InVivoPath provides unified preclinical planning and management for emerging biotechs focused on metabolic disorder, liver disease, fibrosis, neurological and aging therapeutic areas.
We empower lean organizations with immediate access to 20+ years of mastery in in vivo pharmacology and CRO management, without the long-term overhead or logistical friction of a full-time executive hire.
Why InVivoPath
Cross-Modality Depth
Study design and execution experience spanning small molecules, biologics, gene therapy, and combination products — one partner who speaks the language of your entire program, not just one modality.
Model Origination, Not Just Model Use
InVivoPath's approach is grounded in preclinical models developed and validated from the ground up, including a widely-adopted rodent model of NASH/MASH still used across the field today.
CRO Operations From the Inside
Built on a decade managing 50+ concurrent client preclinical programs annually — InVivoPath knows where CRO relationships succeed and where they quietly break down, because we've run that side of the business.
Data-Native Analytics
Custom-built data standardization and machine learning pipelines turn multi-study preclinical datasets into decision-ready insight — a capability most preclinical consultancies don't offer natively.
Seamless Integration
More than a consultancy, we integrate with your team to drive preclinical assets toward clinical success using high-level scientific expertise and deep industry insights.
Preclinical Consulting Services
[01]
Preclinical Strategy & Program Leadership
[02]
CRO Management & Liaison
[03]
Data Standardization & Analytics
[04]
Scientific Due Diligence & Investment Support
Study design, model selection, and go/no-go interpretation aligned to your IND-enabling milestones.
Selection support, scientific point-of-contact services, and quality/timeline oversight across your studies — independent of any CRO's own execution capacity.
Custom pipelines that harmonize and extract insight from multi-study preclinical data.
Scientific assessment of preclinical packages and technical feasibility for investors and biotech M&A pipelines.
Therapeutic Focus
MASH / MASLD/Liver Disease
Obesity and Diabetes
Obesity & Diabetes
Fibrosis
Neurodegeneration
Aging
Over two decades of pharmacological leadership — Innovator of industry-standard MASH/MASLD rodent models used globally — Inventor with 10+ patents and author of 20+ peer-reviewed scientific research publications